Steve Ariens,P.D.’s Post

The Inflation Reduction Act (#IRA) from #CMS will require MA plans to shoulder a larger percentage of Rx financial responsibility to allow members to experience some financial relief from prescription spending. As your plan determines its strategy for implementation, check out our newest blog! We detail 3 action steps to help maintain your plan’s #CAHPS member experience. Click to read more: https://hubs.ly/Q02FHG8J0 #adherenceresolved #MedicareAdvantage #InflationReductionAct #Medicare2024

💡”Ingredient cost matters much more, but rebates are still “king” in terms of value under Part D for health plans. However, health plans must contend with a much lower out-of-pocket maximum in 2025 which could fuel higher utilization than we’ve seen in years past and potential for bad debt with the Medicare Prescription Payment Plan.” Read the rest of the report 👇🏻👇🏻👇🏻

The Inflation Reduction Act changes, specifically the Medicare Part D changes, are here. Out-of-pocket caps, benefit redesign, and net plan liability shifts are just a few areas that plans will need to adjust for. What does this look like? Read our new blog to learn more from Michael Kolodij to learn more. https://lnkd.in/gWMextRk #Medicare #PartD #inflationreductionact #formulary

Since being signed into #law in August 2022, the Inflation Reduction Act (#IRA) is intended to provide “meaningful financial relief” for millions of Americans with #Medicare coverage. Nearly 2 years after its passing, though, unanswered questions around how provisions of the IRA—in particular, the Medicare #drug price negotiation program—persist. According to Corey Ford, vice president of reimbursement and policy insights at Cencora, #stakeholders have been provided clarity around #data submission that #manufacturers must provide, as well as on what #patient engagement sessions will look like. #AXS24 https://lnkd.in/edH6V8ST

The next time someone asks, "What even is a PBM?", this article from the Center for American Progress is a must. It dives into the typical "evils" of #pbms: think spread pricing, price gouging, and market consolidation. Our companies saw all those bad practices too—that's why we agree on the need to do business differently. Transparent pricing can be done in a #pbm and it can be successful... we're proof. https://lnkd.in/eMPUqYBR

Hard to miss the advertisements for diabetes treatments, not to mention all the mentions in entertainment news of Ozempic, Mounjaro and other drugs related to weight loss. You may wonder, “What’s covered by Medicare?” In this recent blog, we answer this question and also provide resources to address how changes to Part D prescription drug coverage impact patients with diabetes. https://lnkd.in/esU8h_cJ Still have questions specific to your condition and coverage? We’re here to get you the answers you need. #medicare #healthinsurance #healthinsurancebrokers #retirement #healthcarecoverage #wellness

We’ve identified five areas that Medicare Advantage plans should consider when shaping their 2025 Part D strategy as the Inflation Reduction Act impacts unfold. #OWHealth

Among the advancements that we'll see in 2025 as a result of the Inflation Reduction Act is the introduction of the Medicare Prescription Payment Plan, a new initiative designed to help beneficiaries manage their out-of-pocket costs with greater predictability. Check out our latest blog to learn more: https://zurl.co/esRX

Check out our newest blog post! Navigating the Financial Impacts of Pharmacy Benefit Managers for Businesses https://lnkd.in/ePtvkANP #AffirmedRx #PBC #PBM #PatientsOverProfits

2024 promises to be an active year in DC and state legislatures regarding PBM regulations. This article outlines the latest big ticket items we're keeping our eye on! https://lnkd.in/gRxvYKgp